Annual Retained Earnings
-$124.71 M
-$71.90 M-136.14%
December 31, 2023
Summary
- As of February 12, 2025, MLYS annual retained earnings is -$124.71 million, with the most recent change of -$71.90 million (-136.14%) on December 31, 2023.
- During the last 3 years, MLYS annual retained earnings has fallen by -$121.11 million (-3361.23%).
- MLYS annual retained earnings is now -3361.23% below its all-time high of -$3.60 million, reached on December 1, 2020.
Performance
MLYS Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$253.57 M
-$56.34 M-28.57%
September 30, 2024
Summary
- As of February 12, 2025, MLYS quarterly retained earnings is -$253.57 million, with the most recent change of -$56.34 million (-28.57%) on September 30, 2024.
- Over the past year, MLYS quarterly retained earnings has dropped by -$128.86 million (-103.33%).
- MLYS quarterly retained earnings is now -1001.96% below its all-time high of -$23.01 million, reached on December 1, 2021.
Performance
MLYS Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
MLYS Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -136.1% | -103.3% |
| 3 y3 years | -3361.2% | -226.9% |
| 5 y5 years | -3361.2% | -226.9% |
MLYS Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -441.9% | at low | -1002.0% | at low |
| 5 y | 5-year | -3361.2% | at low | -1002.0% | at low |
| alltime | all time | -3361.2% | at low | -1002.0% | at low |
Mineralys Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$253.57 M(+28.6%) |
| Jun 2024 | - | -$197.23 M(+26.3%) |
| Mar 2024 | - | -$156.22 M(+25.3%) |
| Dec 2023 | -$124.71 M | -$124.71 M(+24.3%) |
| Sep 2023 | - | -$100.32 M(+29.3%) |
| Jun 2023 | - | -$77.56 M(+18.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | -$65.42 M(+23.9%) |
| Dec 2022 | -$52.81 M(+129.5%) | -$52.81 M(+20.7%) |
| Sep 2022 | - | -$43.74 M(+90.1%) |
| Dec 2021 | -$23.01 M(+538.7%) | - |
| Dec 2021 | - | -$23.01 M |
| Dec 2020 | -$3.60 M | - |
FAQ
- What is Mineralys Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Mineralys Therapeutics?
- What is Mineralys Therapeutics annual retained earnings year-on-year change?
- What is Mineralys Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Mineralys Therapeutics?
- What is Mineralys Therapeutics quarterly retained earnings year-on-year change?
What is Mineralys Therapeutics annual retained earnings?
The current annual retained earnings of MLYS is -$124.71 M
What is the all time high annual retained earnings for Mineralys Therapeutics?
Mineralys Therapeutics all-time high annual retained earnings is -$3.60 M
What is Mineralys Therapeutics annual retained earnings year-on-year change?
Over the past year, MLYS annual retained earnings has changed by -$71.90 M (-136.14%)
What is Mineralys Therapeutics quarterly retained earnings?
The current quarterly retained earnings of MLYS is -$253.57 M
What is the all time high quarterly retained earnings for Mineralys Therapeutics?
Mineralys Therapeutics all-time high quarterly retained earnings is -$23.01 M
What is Mineralys Therapeutics quarterly retained earnings year-on-year change?
Over the past year, MLYS quarterly retained earnings has changed by -$128.86 M (-103.33%)